End of the Bedaquiline patent - a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijid.2023.04.386
PubMed Identifier: 37030652
Publication URI: http://europepmc.org/abstract/MED/37030652
Type: Journal Article/Review
Parent Publication: International Journal of Infectious Diseases
ISSN: 1201-9712